See more : Million Cities Holdings Limited (2892.HK) Income Statement Analysis – Financial Results
Complete financial analysis of cbdMD, Inc. (YCBD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of cbdMD, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Chenming Electronic Tech. Corp. (3013.TW) Income Statement Analysis – Financial Results
- AKM Industrial Company Limited (1639.HK) Income Statement Analysis – Financial Results
- Do-Fluoride New Materials Co., Ltd. (002407.SZ) Income Statement Analysis – Financial Results
- Wisdom Education International Holdings Company Limited (6068.HK) Income Statement Analysis – Financial Results
- Cyclone Metals Limited (CLE.AX) Income Statement Analysis – Financial Results
cbdMD, Inc. (YCBD)
About cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.48M | 24.16M | 35.40M | 44.48M | 41.88M | 23.65M | 8.42M | 4.47M | 2.03M |
| Cost of Revenue | 7.49M | 9.18M | 13.07M | 14.50M | 15.51M | 9.14M | 2.67M | 1.36M | 1.62M |
| Gross Profit | 12.00M | 14.98M | 22.34M | 29.99M | 26.37M | 14.51M | 5.75M | 3.12M | 413.13K |
| Gross Profit Ratio | 61.57% | 62.01% | 63.09% | 67.41% | 62.96% | 61.37% | 68.25% | 69.71% | 20.34% |
| Research & Development | 39.02K | 173.04K | 633.39K | 1.42M | 424.45K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.44M | 9.62M | 15.81M | 21.77M | 23.06M | 0.00 | 1.79M | 0.00 | 0.00 |
| Selling & Marketing | 4.18M | 6.95M | 15.44M | 17.57M | 11.84M | 0.00 | 143.70K | 0.00 | 0.00 |
| SG&A | 12.62M | 16.55M | 31.25M | 39.34M | 34.90M | 28.88M | 1.93M | 3.36M | 0.00 |
| Other Expenses | 2.65M | 7.52M | 7.67M | 8.84M | 9.05M | 28.88M | 5.63M | 3.36M | 4.15M |
| Operating Expenses | 15.31M | 24.25M | 39.56M | 49.60M | 43.95M | 28.88M | 5.63M | 3.36M | 4.15M |
| Cost & Expenses | 22.80M | 33.42M | 52.63M | 64.10M | 59.47M | 38.01M | 8.30M | 4.71M | 5.76M |
| Interest Income | 0.00 | 63.70K | 16.25K | 28.93K | 39.88K | 75.07K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 16.25K | 28.93K | 0.00 | 0.00 | 955.00 | 500.63K | 154.98K |
| Depreciation & Amortization | 1.82M | 2.93M | 2.97M | 2.25M | 1.90M | 289.57K | 222.55K | 71.28K | 44.94K |
| EBITDA | -1.49M | -7.47M | -15.48M | -22.01M | -16.86M | -14.09M | -1.57M | -789.27K | -3.69M |
| EBITDA Ratio | -7.67% | -30.92% | 109.53% | -28.52% | -109.13% | 82.16% | 4.03% | -13.73% | -181.55% |
| Operating Income | -3.32M | -9.27M | 35.81M | -19.62M | -17.58M | 19.14M | 117.10K | -239.29K | -3.73M |
| Operating Income Ratio | -17.02% | -38.37% | 101.14% | -44.10% | -41.98% | 80.94% | 1.39% | -5.35% | -183.76% |
| Total Other Income/Expenses | -384.72K | -13.67M | -52.77M | -4.67M | 28.89M | -32.99M | 0.00 | -1.12M | -154.98K |
| Income Before Tax | -3.70M | -22.94M | -70.08M | -24.29M | 11.31M | -47.79M | 46.83K | -1.36M | -3.89M |
| Income Before Tax Ratio | -18.99% | -94.96% | -197.96% | -54.61% | 26.99% | -202.05% | 0.56% | -30.42% | -191.39% |
| Income Tax Expense | 0.00 | 0.00 | 4.00M | -895.00K | -1.35M | -2.36M | -16.00K | 25.00K | 8.00K |
| Net Income | -3.70M | -22.94M | -74.09M | -23.39M | 12.60M | -45.43M | -412.08K | -1.74M | -3.36M |
| Net Income Ratio | -18.99% | -94.96% | -209.26% | -52.60% | 30.09% | -192.08% | -4.89% | -38.85% | -165.22% |
| EPS | 1.93 | -13.32 | -55.80 | -19.16 | 12.47 | -114.29 | -2.39 | -10.44 | -36.58 |
| EPS Diluted | 1.93 | -13.32 | -55.80 | -19.16 | 12.19 | -114.29 | -2.39 | -10.44 | -36.58 |
| Weighted Avg Shares Out | 4.31M | 2.02M | 1.33M | 1.22M | 980.90K | 397.49K | 172.06K | 166.49K | 91.75K |
| Weighted Avg Shares Out (Dil) | 4.31M | 2.02M | 1.33M | 1.22M | 1.00M | 397.49K | 172.22K | 166.49K | 91.75K |
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie,...
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw...
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q3 2024 Earnings Conference Call August 14, 2024 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Chief Executive Officer & Chief Financial Officer Conference Call Participants Thomas McGovern - Maxim...
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
cbdMD Achieves Significant Reduction in Operating Loss as Operational Efficiencies Significantly Improve in Q3 2024 Charlotte, North Carolina--(Newsfile Corp. - August 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) one of the nation's leading and most highly trusted...
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - August 5, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m.,...
cbdMD Announces Publication of Human Clinical Trial Data
Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's human clinical trial...
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw...
Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes
There's bad news brewing for some cannabis stocks. Even as cannabis rescheduling efforts continue, a key segment of the wider market is coming up on massive disruption: a hemp ban.
cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions
Charlotte, North Carolina--(Newsfile Corp. - May 24, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company") is thrilled to announce the launch of its highly anticipated ATRx Labs Premium Mushroom Line, available exclusively at GNC stores nationwide....
cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer
Charlotte, North Carolina--(Newsfile Corp. - May 16, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) a leading name in premium CBD offerings, is excited to introduce its newest relaxation innovation: "Max Chill" Dragon Fruit D9 Gummies. Crafted to elevate...
Source: https://incomestatements.info
Category: Stock Reports